- Home
- TPH vs FOLD Comparison
TPH vs FOLD Comparison
Compare TPH & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- FOLD
- Stock Information
- Founded
- TPH 2009
- FOLD 2002
- Country
- TPH United States
- FOLD United States
- Employees
- TPH N/A
- FOLD N/A
- Industry
- TPH Homebuilding
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- TPH Consumer Discretionary
- FOLD Health Care
- Exchange
- TPH Nasdaq
- FOLD Nasdaq
- Market Cap
- TPH 2.9B
- FOLD 2.9B
- IPO Year
- TPH N/A
- FOLD 2007
- Fundamental
- Price
- TPH $31.82
- FOLD $7.50
- Analyst Decision
- TPH Buy
- FOLD Strong Buy
- Analyst Count
- TPH 5
- FOLD 9
- Target Price
- TPH $43.00
- FOLD $17.00
- AVG Volume (30 Days)
- TPH 1.1M
- FOLD 3.0M
- Earning Date
- TPH 04-24-2025
- FOLD 05-08-2025
- Dividend Yield
- TPH N/A
- FOLD N/A
- EPS Growth
- TPH 40.00
- FOLD N/A
- EPS
- TPH 4.83
- FOLD N/A
- Revenue
- TPH $4,492,870,000.00
- FOLD $528,294,999.00
- Revenue This Year
- TPH N/A
- FOLD $21.91
- Revenue Next Year
- TPH $6.89
- FOLD $22.22
- P/E Ratio
- TPH $6.59
- FOLD N/A
- Revenue Growth
- TPH 20.93
- FOLD 32.29
- 52 Week Low
- TPH $29.91
- FOLD $7.39
- 52 Week High
- TPH $47.78
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- TPH 47.02
- FOLD 23.10
- Support Level
- TPH $31.20
- FOLD $8.40
- Resistance Level
- TPH $32.49
- FOLD $8.06
- Average True Range (ATR)
- TPH 0.96
- FOLD 0.28
- MACD
- TPH 0.07
- FOLD -0.10
- Stochastic Oscillator
- TPH 62.62
- FOLD 5.88
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company designs and builds single-family homes and condominiums through its portfolio of six regional housing brands. Its largest regional brands include Maracay Homes, which operates in Arizona, and TRI Pointe and Pardee Homes, which operate in California, Nevada, and Colorado. From a geographic perspective, California is TRI Pointe's largest source of revenue, followed by Arizona and Nevada. The company also operates in Texas, Oregon, and Virginia. TRI Pointe completes approximately 4,000 homes annually with an average selling price around $500,000. TRI Pointe also is involved in the sale and development of land.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.